 days
less with CAC; at
6 months and 1 year,
no difference in QoL or
closure rates

Prospective
nonrandomized,
comparative trial

Calik et al,172
2019

412 Limbs in 400
patients with
varicose veins
(C2-C4)

EVLA (n ¼ 204)

CACa (n ¼ 208)

Periprocedural pain less
after CAC (P < .001);
induration,
ecchymosis, and
paresthesia rates
higher with EVLA (P <
.001) at 12 months; QoL
and closure rates
similar (96.6% vs
94.1%)

Prospective
nonrandomized,
comparative study

Ovali et al,188
2019

244 Patients with
varicose veins
(C2-C4)

RFA of GSV
(n ¼ 128)

CACa of GSV
(n ¼ 116)

Technical success 100%
in both groups; early
severe pain,
ecchymosis, and
discomfort
signiﬁcantly greater
after RFA (P < .05);
occlusion rates and
QoL similar at 1 year

Nonrandomized
retrospective,
comparative study

(Continued on next page)

248

Gloviczki et al

Journal of Vascular Surgery: Venous and Lymphatic Disorders
March 2023

Table III. Continued.
Investigator

Population

Intervention

Comparison

Outcomes

Study design

Vahaaho et al,191
2021

132 Patients with
varicose veins
(C2-C4)
randomized
(intention to
treat)

EVLA (n ¼ 34);
RFA (n ¼ 33);
3-year followup, 31 and 25

MOCA (n ¼ 65);
3-year followup, 50)

At 3 years, closure rate
signiﬁcantly lower for
MOCA than EVLA or
RFA (82% vs 